Stock Scorecard



Stock Summary for Spectral AI Inc - Class A (MDAI) - $1.83 as of 1/27/2026 3:21:25 AM EST

Total Score

10 out of 30

Safety Score

8 out of 100

Currently on the following lists
Small Cap Stock List
Tim's Recommendation
Possible Buy

Growth List Algorithm Criteria for MDAI

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for MDAI

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for MDAI

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for MDAI

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for MDAI (8 out of 100)

Stock Price Rating (Max of 10) 2
Historical Stock Price Rating (Max of 10) 5
Stock Price Trend (Max of 10) 1
Book Value (Max of 10) 1
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 3
Analyst Strong Buy Ratings (Max of 5) 0
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 0
Trading Volume (Max of 10) 6
Price to Earnings (Max of 10) 0
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) -10

Latest News for for MDAI

Spectral AI, Inc. (NASDAQ:MDAI) Stock Catapults 29% Though Its Price And Business Still Lag The Industry 1/27/2026 6:30:00 PM
Spectral AI Reports Q3 2025 Financial Results 12/6/2025 6:08:00 AM
Spectral AI, Inc. SEC 10-Q Report 11/18/2025 10:09:00 AM
Spectral AI (NASDAQ:MDAI) Price Target Cut to $3.00 by Analysts at BTIG Research 11/17/2025 4:31:00 AM
BTIG Maintains Spectral AI (MDAI) Buy Recommendation 11/12/2025 7:03:00 AM
Spectral AI, Inc. Reports Q3 2025 Financial Results and Advances in FDA Submission with Strong Cash Position 11/11/2025 9:14:00 PM
Spectral AI Inc. (MDAI) Eyes $7.6M Capital Raise to Accelerate DeepView System Development 10/28/2025 7:28:00 AM
Spectral AI (NASDAQ: MDAI) to Report Q3 Results Nov. 11; Investor Call and Webcast 10/28/2025 4:31:00 AM
Spectral AI, Inc. Announces $7.6 Million Offering to Support Expansion of DeepView® System | MDAI Stock News 10/23/2025 12:44:00 PM
Spectral AI (NASDAQ: MDAI) prices $7.6M offering to expand DeepView; 2026 readiness prep 10/23/2025 7:09:00 AM

Financial Details for MDAI

Company Overview

Ticker MDAI
Company Name Spectral AI Inc - Class A
Country N/A
Description Spectral AI Inc. (MDAI) is a pioneering predictive analytics firm headquartered in Dallas, Texas, specializing in revolutionizing wound care treatment through the integration of advanced artificial intelligence and optical technologies. By employing state-of-the-art machine learning techniques, the company seeks to enhance clinical outcomes and elevate patient care, positioning itself as a frontrunner in healthcare innovation. With its strong dedication to redefining medical technology standards, Spectral AI is strategically positioned to leverage opportunities in a rapidly evolving healthcare environment, thereby offering institutional investors a compelling prospect in a high-growth sector.
Sector Name HEALTHCARE
Industry Name MEDICAL DEVICES
Most Recent Quarter 9/30/2025
Next Earnings Date N/A

Stock Price History

Last Day Price 1.83
Price 4 Years Ago 10.10
Last Day Price Updated 1/27/2026 3:21:25 AM EST
Last Day Volume 677,399
Average Daily Volume 311,787
52-Week High 3.21
52-Week Low 1.04
Last Price to 52 Week Low 75.96%

Valuation Measures

Trailing PE N/A
Industry PE 30.59
Sector PE 95.54
5-Year Average PE -24.71
Free Cash Flow Ratio 5.38
Industry Free Cash Flow Ratio 31.09
Sector Free Cash Flow Ratio 26.23
Current Ratio Most Recent Quarter 0.85
Total Cash Per Share 0.34
Book Value Per Share Most Recent Quarter -0.30
Price to Book Ratio 29.88
Industry Price to Book Ratio 2.60
Sector Price to Book Ratio 22.01
Price to Sales Ratio Twelve Trailing Months 2.31
Industry Price to Sales Ratio Twelve Trailing Months 2.70
Sector Price to Sales Ratio Twelve Trailing Months 18.97
Analyst Buy Ratings 2
Analyst Strong Buy Ratings 0

Share Statistics

Total Shares Outstanding 30,688,900
Market Capitalization 56,160,687
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Previous Dividend Amount 0.0000
Current Dividend Amount 0.0000
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth 26.56%
Reported EPS 12 Trailing Months -0.75
Reported EPS Past Year -0.33
Reported EPS Prior Year -0.80
Net Income Twelve Trailing Months -16,365,000
Net Income Past Year -15,315,000
Net Income Prior Year -20,854,000
Quarterly Revenue Growth YOY -53.60%
5-Year Revenue Growth 795.16%
Operating Margin Twelve Trailing Months -88.10%

Balance Sheet

Total Cash Most Recent Quarter 10,495,000
Total Cash Past Year 5,157,000
Total Cash Prior Year 4,790,000
Net Cash Position Most Recent Quarter 3,914,000
Net Cash Position Past Year -32,843,000
Long Term Debt Past Year 38,000,000
Long Term Debt Prior Year 175,000
Total Debt Most Recent Quarter 6,581,000
Equity to Debt Ratio Past Year -0.24
Equity to Debt Ratio Most Recent Quarter 0.00
Total Stockholder Equity Past Year -7,251,000
Total Stockholder Equity Prior Year -1,709,000
Total Stockholder Equity Most Recent Quarter -8,203,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months -9,400,000
Free Cash Flow Per Share Twelve Trailing Months -0.31
Free Cash Flow Past Year -9,199,000
Free Cash Flow Prior Year -13,240,000

Options

Put/Call Ratio 0.00
Has Options False
Liquidity Rating None

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 0.00
MACD Signal 0.00
20-Day Bollinger Lower Band 1.16
20-Day Bollinger Middle Band 1.83
20-Day Bollinger Upper Band 2.50
Beta 0.94
RSI 69.97
50-Day SMA 0.00
150-Day SMA 0.00
200-Day SMA 0.00

System

Modified 1/29/2026 3:14:50 AM EST